Fund Comparison Guide · Updated November 2026

ARKVX vs DXYZ vs VCX 2026

The ARK Venture Fund, Destiny Tech100 and the Fundrise Innovation Fund are three registered funds that give any brokerage customer indirect exposure to overlapping portfolios of private technology companies, Anthropic and OpenAI among them, alongside SpaceX, which listed on Nasdaq in June 2026. The difference is the price you transact at. ARKVX issues and repurchases its shares at net asset value through the fund. DXYZ and VCX trade at market prices on the NYSE, where they have changed hands far above and, this month, below their last reported NAVs. This guide compares them from their shareholder reports, repurchase notices and prospectus supplements.

Guide Thesis

Same companies. Three prices for them.

ARKVX: $500 minimum, bought at NAV, 2.90% net expenses, 5% quarterly repurchases. DXYZ: NYSE, 2.50% fee on gross assets, $24.37 against the $34.30 NAV of June 30, 2026. VCX: NYSE, 1.85% fee, 2.57% reported expenses, $20.05 against the $21.70 NAV of September 8, 2026. Prices are November 6, 2026 closes; the NAVs are the last each fund filed.

The three expense ratios sit within 33 basis points of one another. The three entry prices do not.

At the November 6, 2026 closes, $100 bought $100 of ARKVX net asset value (the fund transacts at NAV), about $108 of VCX's last filed NAV, dated September 8, 2026, and about $141 of DXYZ's last reported NAV, dated June 30, 2026. Those are comparisons with dated marks, not same-day discounts. In August the same $100 bought far less than $100 of either listed fund's NAV.

ARKVX vs DXYZ vs VCX comparison 2026

The Core Decision

Do you want the adviser's price or the market's?

ARKVX hands pricing to ARK's valuation process at both ends and limits the exit to a quarterly 5% window. DXYZ and VCX hand pricing to the NYSE, which has valued the same kind of portfolio at anything from eighteen times a quarterly NAV to 29% below a four-month-old one. The portfolios overlap heavily in Anthropic, OpenAI and SpaceX; the experience of owning them does not.

Buys and sells at NAV

ARKVX

Shares are issued by the fund at net asset value, $500 minimum, and repurchased at NAV in quarterly 5% offers. No market premium or discount; no market to sell into between offers.

Lowest reported expense ratio

VCX

2.57% for the year to March 31, 2026 on a 1.85% management fee. The three figures are not on one basis: ARKVX's 2.90% is net of a waiver (3.45% gross) for the year to July 31, 2026, DXYZ's 2.82% is an unaudited annualized half-year figure (4.53% for 2025), and VCX's own September 2026 prospectus estimates 3.40% at the offering price.

Deepest discount to last NAV

DXYZ

$24.37 on November 6, 2026 against the June 30, 2026 NAV of $34.30, about 29% below a four-month-old mark. In the second quarter of 2024 the quarter's high close of $99.79 stood 1,837.6% above the $5.15 NAV reported for that quarter.

The three funds at a glance

 ARKVXDXYZVCX
Full nameARK Venture Fund, Class D (ARK Venture & Innovation Fund from November 24, 2026)Destiny Tech100 Inc.Fundrise Innovation Fund, LLC
StructureInterval fund; bought from the fund at NAV; quarterly 5% repurchase offersListed closed-end fund, NYSE since March 26, 2024Listed closed-end fund, NYSE since March 19, 2026; a Fundrise tender offer fund before that
Net assets$1,309 million (October 31, 2026)$1,634.8 million (June 30, 2026), 57.5% in a money market fund$776.97 million (June 30, 2026)
Management fee / latest expense ratio2.75% / 2.90% net, 3.45% gross, year to July 31, 2026 (annual report)2.50% of gross assets / 2.82% annualized, unaudited first half 2026 (semi-annual report); 4.53% in 20251.85% / 2.57%, year to March 31, 2026 (annual report); 3.40% estimated in the September 2026 supplement
Last reported NAV per share$59.45 at August 31, 2026 (repurchase notice)$34.30 at June 30, 2026 (August 31 supplement)$21.70 at September 8, 2026 (prospectus supplement)
Share price, November 6, 2026Not traded; transactions at NAV$24.37, about 29% below the June 30 NAV (market data)$20.05, about 7.6% below the September 8 NAV (market data)
Latest NAV total return62.94% (year to July 31, 2026); 44.20% one year to September 30, 202672.12% (first half 2026); 209.59% (2025), with issuance accretion the larger part68.39% (year to March 31, 2026)
Minimum and how to buy$500 through participating brokerages and platforms; no accreditationOne share on the NYSEOne share on the NYSE

$10,000 in each, side by side

 ARKVXDXYZVCX
What you buy$10,000 of net asset value, issued by the fund at the next NAV; about 168 shares at the $59.45 NAV of August 31, 2026. No load on Class D.About 410 shares at the $24.37 close of November 6, 2026, which is about $14,070 of NAV measured against the June 30 mark of $34.30. At the August 27 high of $35.40 the same $10,000 bought about $9,690 of that NAV.About 499 shares at the $20.05 close of November 6, 2026, about $10,820 of NAV against the September 8 mark of $21.70. At the September 8 close of $38.12 it was about $5,693.
Annual cost to youAbout $290 at the 2.90% net ratio; $345 at the 3.45% gross ratio if ARK's waiver ended.About $282 at the 2.82% annualized first-half 2026 ratio; $453 at the 2025 ratio. The 2.50% fee is charged on gross assets including cash.About $257 at the 2.57% ratio for the year to March 31, 2026.
Your Anthropic, OpenAI and SpaceXAbout $445, $770 and $579 of NAV at the October 31, 2026 weights.About $2,030, $370 and $1,490 of June-dated NAV at the June 30, 2026 weights, before the fund deployed more of its cash.About $1,790 and $1,340 of September-dated NAV at the March 31, 2026 Anthropic and OpenAI weights; SpaceX not among the five largest named issuers.
When you see the money againIn a quarterly repurchase offer at NAV, 5% of shares (up to 7% at the fund's option), prorated if oversubscribed. No distributions in fiscal 2026.Any NYSE session at the market price. No distributions in any reported period.Any NYSE session at the market price. $0.21 per share distributed in fiscal 2026, all capital gain.
Tax reportingForm 1099; regulated investment company; no K-1.Form 1099; intends to qualify as a regulated investment company; no K-1.Form 1099; regulated investment company since fiscal 2026 after C corporation years, with $3.85 million of deferred tax accrued in NAV at March 31, 2026.
What goes wrongTenders exceed the offer and you are prorated, or you miss a deadline and wait a quarter, while ARK's Level 3 marks are the only price.The premium you paid compresses, as it did for 2025 holders who lost 47.96% at market while NAV rose 209.59%; or you buy at a discount to a stale NAV that the next quarterly report resets.The same premium risk, shown by the fall from $44.62 on August 24 to $20.05 on November 6, 2026; plus the built-in gains tax if pre-2026 gains are realized within five years.

TL;DR

The comparison in two paragraphs

These are three ways of owning a similar list of private companies. ARKVX is the only one you buy from the fund at net asset value, and the only one you cannot sell on a day of your choosing: its quarterly offers take 5% of shares at NAV, and in fiscal 2026 every share tendered was bought. It also carries the highest management fee (2.75%), and its latest top ten, at October 31, 2026, showed OpenAI 7.70%, SpaceX 5.79% and Anthropic 4.45%. DXYZ and VCX trade on the NYSE. Their management fees are lower (2.50% on gross assets and 1.85%), and their last published snapshots, older and on different bases, showed DXYZ with Anthropic at 14.4% and SpaceX at 10.6% of its portfolio at June 30, 2026 and VCX with Anthropic at 16.5% and OpenAI at 12.4% of net assets at March 31, 2026.

What the listed pair adds is a second price that has nothing to do with the portfolio. DXYZ's second-quarter 2024 high close stood 1,837.6% above that quarter's reported NAV, and the fund attributes most of its 2025 NAV growth to selling shares above NAV; VCX disclosed a 75.7% premium on September 8, 2026 in the supplement that authorized a $1 billion at-the-market program. By November 6, 2026 both closed below their last reported NAVs, DXYZ by about 29% against a June mark and VCX by about 7.6% against a September one. The right fund depends on whether you want to buy the adviser's NAV and wait for a window, or buy the market's price and keep a daily exit.

If you read nothing else: scroll to the head-to-head comparison sections →

ARKVX suits you if

  • → You will not pay a market premium for a Level 3 portfolio
  • → You can wait for a quarterly window and accept proration
  • → You want the broadest list of names, including Kalshi, Ayar Labs and Stripe
  • → You are starting at $500

DXYZ suits you if

  • → You want the heaviest SpaceX weight of the three
  • → You will check the premium or discount against the latest quarterly NAV before every trade
  • → You accept a 2.50% fee charged on cash the fund has not deployed
  • → You want a daily exit

VCX suits you if

  • → You want the heaviest Anthropic and OpenAI weights and the lowest audited expense ratio
  • → You want the economic issuers named and sized in the annual report
  • → You accept a built-in gains tax overhang from the fund's C corporation years
  • → You want a daily exit

1,837.6%

DXYZ high close over quarterly NAV, Q2 2024

The quarter's high close of $99.79 against the $5.15 NAV reported for that quarter, from the fund's own quarterly premium table. The same table shows lows of (1.1)% and (3.1)% in the fourth quarter of 2025 and the first quarter of 2026.

75.7%

VCX premium to NAV, September 8, 2026

$38.12 against $21.70, disclosed on the cover of the prospectus supplement that authorized a $1 billion at-the-market program. On November 6, 2026 the shares closed at $20.05.

100%

ARKVX shares tendered that were bought, fiscal 2026

Four offers, 1.50% to 4.23% of outstanding shares tendered against a 5% offer each time, all repurchased at NAV. The fund may prorate if tenders exceed 7%.

Head to Head

ARKVX vs DXYZ vs VCX, section by section

One wrapper, two ways to trade it

ARKVX vs DXYZ vs VCX: Structure

All three are non-diversified closed-end management investment companies registered under the Investment Company Act of 1940, open to any US investor, audited, and filing quarterly holdings on EDGAR. ARKVX is an interval fund: it sells its own shares continuously at NAV and commits, under Rule 23c-3, to quarterly repurchase offers. DXYZ listed on the NYSE in March 2024 and VCX in March 2026, after three and a half years as a Fundrise-only tender offer fund. A listed fund never buys its shares back at NAV; the exchange is the exit, at the market's price.

Legal form and tickerARKVX: ARK Venture Fund, a Delaware statutory trust, interval fund, Investment Company Act file 811-23778, Class D ticker ARKVX (Class S ARKSX, Class U ARKUX); renamed ARK Venture & Innovation Fund effective November 24, 2026. DXYZ: Destiny Tech100 Inc., Maryland corporation, listed closed-end fund, file 811-23802, NYSE since March 26, 2024. VCX: Fundrise Innovation Fund, LLC, Delaware LLC, listed closed-end fund, file 811-23708, NYSE since March 19, 2026.
Adviser and auditorARKVX: ARK Investment Management LLC (Catherine Wood), auditor Ernst & Young. DXYZ: DX Advisors LLC since April 29, 2026, succeeding Destiny Advisors LLC (founder Sohail Prasad), auditor KPMG. VCX: Fundrise Advisors, LLC, auditor KPMG.
SizeARKVX: $1,309 million of net assets at October 31, 2026 (fund site; $1.16 billion in the July 31, 2026 annual report). DXYZ: $1,634.8 million at June 30, 2026, of which $939.7 million was a money market fund. VCX: $776.97 million at June 30, 2026.
Minimum and accessARKVX: $500, no accreditation, through participating brokerages and platforms; share class depends on the intermediary. DXYZ and VCX: one share on the NYSE through any brokerage.
InceptionARKVX: September 23, 2022. DXYZ: registered May 2022, listed March 2024. VCX: investment operations July 25, 2022, listed March 2026.

Verdict

Pick the pricing mechanism first. An interval fund gives you the adviser's NAV going in and coming out, with a quarterly door. A listed fund gives you a daily door and lets the market decide what your shares are worth relative to that NAV.

The number that moved the most this year

NAV vs share price

ARKVX has one price, its NAV: $59.45 per share on August 31, 2026 per the September repurchase notice. DXYZ and VCX each have two, and the gap between them has swung from extreme premiums to discounts in a matter of months. DXYZ's own quarterly table puts the second quarter of 2024's high close of $99.79 at 1,837.6% above the $5.15 NAV reported for that quarter, and the fund attributes most of its 2025 NAV growth to selling new shares above NAV through its at-the-market program ($9.95 of the $13.49 rise). VCX disclosed a $38.12 close against a $21.70 NAV on September 8, 2026, a 75.7% premium, on the cover of the prospectus supplement that authorized a $1 billion at-the-market program. By November 6, 2026 both listed funds had fallen below their last reported NAVs: DXYZ $24.37 against $34.30 (June 30), VCX $20.05 against $21.70 (September 8). Over the three months to November 6, DXYZ's high close was $35.40 (August 27) and VCX's was $44.62 (August 24).

Last reported NAVARKVX: $59.45 (August 31, 2026, repurchase notice); $54.78 Class D at July 31, 2026 (annual report). DXYZ: $34.30 (June 30, 2026, semi-annual report and August 31 prospectus supplement); the next quarterly NAV is due with the September 30 holdings report. VCX: $21.70 (September 8, 2026, prospectus supplement); $18.97 audited at March 31, 2026.
Share price, November 6, 2026 closeARKVX: no market price; transactions at NAV. DXYZ: $24.37, about 29% below the June 30 NAV. VCX: $20.05, about 7.6% below the September 8 NAV. Market data, not filed figures.
Premium historyDXYZ, from its quarterly table of high and low closes against the NAV reported for each quarter: 1,837.6% at the second-quarter 2024 high close of $99.79 (quarterly NAV $5.15); quarterly lows of 53% to 356% above NAV through the third quarter of 2025; (1.1)% and (3.1)% at the lows of the fourth quarter of 2025 and first quarter of 2026; 151% at $61.66 on May 21, 2026. VCX: first traded at $31.25 on March 19, 2026 against a $18.97 NAV twelve days later; 75.7% premium on September 8, 2026; fell from $38.12 to $29.62 in the three weeks to September 30.
New shares above NAVDXYZ: documented issuance through an at-the-market program with Jefferies; $959.6 million of proceeds in the first half of 2026; issuance above NAV accreted $7.10 per share to existing holders in that half and $9.95 in 2025. VCX: an authorized program of up to $1 billion through Jefferies from September 10, 2026, at no less than NAV plus commission; no filing located by November 8, 2026 confirms sales under it. ARKVX: continuous issuance at NAV, neither accretive nor dilutive.
What $100 buysARKVX: $100 of NAV, because the fund transacts at NAV. DXYZ: about $141 of the June 30, 2026 NAV at the November 6 close, a mark that predates $169 million of deployments the fund reported by August 27 and whatever its private valuations did in the third quarter. VCX: about $108 of the September 8, 2026 NAV at the November 6 close.

Verdict

A premium is a market opinion about scarcity, and it reverses. Buyers who paid DXYZ's or VCX's August highs have lost 31% and 55% at the November 6 closes while the funds' reported NAVs, where disclosed, moved far less. ARKVX buyers never faced that variable, and never had a day on which they could sell.

Less than a point apart, on different bases

ARKVX vs DXYZ vs VCX: Fees

The headline fees run 1.85% (VCX), 2.50% (DXYZ) and 2.75% (ARKVX), and the realized expense ratios compress toward one another because fixed costs are spread over larger funds. VCX reported 2.57% for the year to March 31, 2026 with no waiver needed. ARKVX reported 3.45% before and 2.90% after ARK's waivers for the year to July 31, 2026; the 2.90% cap stays until the board terminates it and ARK cannot recoup. DXYZ charges 2.50% on gross assets, including the cash it has not yet deployed, and reported 2.82% annualized for the first half of 2026 after 4.53% in 2025 and 6.28% in 2024, when the fund was small. None of the three charges carried interest at the adviser level; two of DXYZ's twenty special purpose vehicles carry 20% and 10% carried interest underneath, and VCX's and ARKVX's third-party vehicles may carry fees that do not appear in the fund's ratio.

Management feeARKVX: 2.75% of average daily net assets plus 0.15% servicing (Class D). DXYZ: 2.50% of average gross assets, quarterly, so it applies to cash held. VCX: 1.85% of average daily net assets; a 2.50% proposal failed a shareholder vote in February 2026.
Latest expense ratioARKVX: 3.45% gross, 2.90% net, fiscal year to July 31, 2026 (fund site, as of October 31, 2026: 3.49% gross, 2.90% net). DXYZ: 2.82% annualized, six months to June 30, 2026; 4.53% in 2025. VCX: 2.57% including interest expense, year to March 31, 2026; the September 2026 prospectus supplement estimates 3.40% at the offering price.
Waivers and capsARKVX: operating expenses capped at 2.90% (Class D) until the board ends the agreement; no recoupment. DXYZ: no expense cap; the adviser deferred fees in 2024 when the fund disclosed going-concern indicators. VCX: 3.00% cap with three-year recoupment, not needed in fiscal 2026.
Loads and transaction costsARKVX Class D: no load, no repurchase fee charged by the fund; Class S carries a load of up to 3.50%. DXYZ and VCX: brokerage commission only, plus the bid-ask spread and the premium or discount.
Fees underneathDXYZ: 20 SPVs at June 30, 2026 with no ongoing management fees and carried interest of 20% and 10% on two. VCX and ARKVX: third-party vehicles and funds that may charge management fees and carry; neither fund itemizes the performance allocation.

Verdict

On a $10,000 position the annual difference between the cheapest and the most expensive of the three is about $33. The premium or discount on the day you buy a listed fund has been worth hundreds of times that. Compare fees, then spend your attention on price against NAV.

Overlapping names, different weights and dates

Holdings: Anthropic, OpenAI, SpaceX

The three portfolios meet at the top of the private market. ARKVX's ten largest positions at October 31, 2026 were OpenAI 7.70%, Kalshi 5.89%, SpaceX 5.79%, Ayar Labs 5.73%, Anthropic 4.45%, Tenstorrent 4.22%, Stripe 4.10%, Lila Sciences 3.97%, Crusoe 3.52% and Figure AI 2.48%, with 77.41% of the fund in private companies and 22.59% in public ones (SpaceX listed in June 2026). DXYZ at June 30, 2026 reported economic exposure to 37 companies led by Anthropic 14.4%, SpaceX 10.6% and OpenAI 2.6% of the portfolio, with 57.5% of net assets still in a money market fund and $169 million of further deployments by August 27. VCX's annual report at March 31, 2026 named Anthropic 16.5%, Databricks 14.1%, OpenAI 12.4%, Anduril 5.5% and Ramp 4.1% of net assets, five companies making 52.6% of the fund, across 62 positions at June 30.

AnthropicARKVX 4.45% (October 31, 2026). DXYZ 14.4% of portfolio (June 30, 2026). VCX 16.5% of net assets (March 31, 2026).
OpenAIARKVX 7.70%, its largest position. DXYZ 2.6%. VCX 12.4%.
SpaceXARKVX 5.79%, now a listed holding. DXYZ 10.6%, held through SPVs and forward contracts. VCX: not among the five largest economic issuers named in the annual report.
Cash and concentrationARKVX: 3.1% cash at July 31, 2026; top ten 46.6% at September 30. DXYZ: 57.5% money market at June 30, 2026, after $959.6 million of at-the-market proceeds in six months. VCX: 5.37% Treasury money market at June 30, 2026; largest single position 16.50% (SaxeCap Advisors VIII, LP).
ValuationAll three carry most holdings at Level 3, valued by the adviser under board-overseen procedures: ARKVX 68% of net assets at July 31, 2026; VCX 72.9% at June 30, 2026; DXYZ's SPVs and private positions were about 42% of net assets at June 30, 2026 with the rest in cash.

Verdict

On the snapshots each fund has published, VCX showed the heaviest Anthropic and OpenAI weights, DXYZ the heaviest SpaceX weight, and ARKVX a longer list that adds Kalshi, Ayar Labs, Tenstorrent and Stripe, with OpenAI at 7.70% sitting between the other two. The dates differ by seven months and the denominators differ, so treat these as the last published weights, not a ranking of exposure today. Holding all three largely triples the same companies at three dates and three prices.

A quarterly door at NAV, or a daily door at the market's price

Liquidity: how you get out

ARKVX offers to repurchase 5% of its outstanding shares each quarter at the NAV of the Repurchase Pricing Date; the September 2026 offer ran from September 2 to a September 30 deadline. If holders tender more than 5%, the fund may add 2% and otherwise prorates. In the four offers of fiscal 2026, holders tendered 1.50%, 1.51%, 1.73% and 4.23% of shares and every share was bought, continuing a record of 14 offers since March 2023. DXYZ and VCX have no repurchase program at all: a holder sells on the NYSE, in any session, at the prevailing price. VCX ran quarterly tender offers at NAV until its listing; the last was filed in January 2026 at $18.19 per share.

MechanismARKVX: quarterly repurchase offers under Rule 23c-3, 5% of shares at the NAV of the Repurchase Pricing Date, normally the same day as the request deadline with discretion to price later; offers in March, June, September and December. DXYZ and VCX: a sell order on the NYSE at the market price on any trading day; no fund repurchases.
Tested capacityARKVX: 14 offers through June 2026, 1.50% to 5.00% of shares repurchased; all shares tendered in fiscal 2026 were bought. DXYZ: average daily trading volume on the NYSE; no fund buyback. VCX: listed since March 2026; the pre-listing lockup expired August 13, 2026, a month early.
Price risk at exitARKVX: none relative to NAV; the NAV itself is set after your request deadline. DXYZ and VCX: the premium or discount on the day your order fills, which moved from a 75.7% premium to a discount for VCX in two months of 2026.
Timing riskARKVX: a request that misses the deadline waits a quarter; a prorated request leaves a remainder. DXYZ and VCX: a sell order can be placed any trading day; execution depends on a buyer at that price.
DistributionsARKVX: none in fiscal 2026. DXYZ: none in any reported period. VCX: $0.21 per share in fiscal 2026, all capital gain.

Verdict

If you may need to sell on a date you choose, only the listed funds let you place a sell order that day, at whatever price other buyers offer. If you want the price basis fixed to NAV and can wait for a window, ARKVX is the one built for that, with proration the risk to plan for.

Why do DXYZ and VCX trade above or below NAV?

Short answer

Because the fund does not stand behind its share price. A listed closed-end fund's shares change hands between investors at whatever the market pays, while the adviser reports NAV from private valuations, quarterly for DXYZ. Scarcity drove premiums of 1,837.6% (DXYZ's second-quarter 2024 high close over that quarter's NAV) and 75.7% (VCX, September 8, 2026); more supply arrived while both prices fell, documented for DXYZ in its at-the-market issuance and for VCX in its lockup expiry, with its $1 billion program authorized but no sales under it confirmed in a filing. On November 6, 2026 both closed below their last reported NAVs. ARKVX never has this problem because it only transacts at NAV.

Both listed funds have documented the swing themselves. DXYZ's May 2026 shelf registration carries a quarterly table of high and low closes against the NAV reported for each quarter: a second-quarter 2024 high close of $99.79 against a $5.15 quarterly NAV, quarterly lows still 53% to 356% above NAV through the third quarter of 2025, then lows of (1.1)% and (3.1)% at the turn of the year, then a 151% premium at $61.66 on May 21, 2026. The fund's financial highlights add the other half of the story: of the $13.49 rise in NAV per share during 2025, $9.95 came from selling new shares above NAV, and the market-price return to a shareholder that year was (47.96)%.

VCX's record is shorter and the same shape. The shares opened at $31.25 on March 19, 2026 against an audited $18.97 NAV twelve days later; the September 10 prospectus supplement put the September 8 close at $38.12 against a $21.70 NAV and warned that buyers at a premium "may incur significant losses even if NAV is stable or increases." The pre-listing lockup had expired a month early on August 13, and the supplement authorized up to $1 billion of new shares; no filing AltStreet located confirms sales under that authorization. The price fell to $29.62 by September 30 and $20.05 by November 6, 2026.

Discounts are no safer to assume than premiums. On November 6, DXYZ at $24.37 sat about 29% below its June 30 NAV of $34.30, but that NAV predates the $169 million of deployments the fund reported through August 27 and whatever its private marks did in the third quarter. VCX at $20.05 sat 7.6% below a September 8 NAV. A buyer who treats either gap as a bargain is taking a view on a number that the next filing will replace. ARKVX avoids the question in both directions: the fund issues shares at NAV and buys them back at NAV, and the price risk is in ARK's marks rather than in the market.

How do I sell ARKVX, and can my repurchase request be prorated?

Short answer

You submit a repurchase request through your brokerage before the quarterly Repurchase Request Deadline, and the fund buys your shares at the NAV struck on the Repurchase Pricing Date. The offer is for 5% of outstanding shares; if more is tendered the fund may add up to 2% and otherwise buys pro rata, so a request can be prorated. In fiscal 2026 tenders ran 1.50% to 4.23% of shares and every share tendered was bought. A missed deadline waits a quarter.

The September 2026 notice spells out the mechanics. The offer opened on September 2 and closed at the NYSE close on September 30, the Repurchase Request Deadline; the NAV used is the one calculated on the Repurchase Pricing Date, which the notice says will normally be the same day as the deadline, with the fund able to price later, and which may differ from the NAV on the day you decide to tender. The result of that offer had not been reported in a filing AltStreet located by November 8, 2026. The notice also reports the fund's NAV of $59.45 at August 31, 2026 and reminds holders that a repurchase is a taxable event and that a nominee may charge its own transaction fee. The fund has run this cycle every quarter since March 2023.

The record is good and the terms are the terms. Fourteen offers through June 2026 repurchased between 1.50% and 5.00% of shares; the four in fiscal 2026 bought every share tendered. But the offer is 5% and the fund's discretion to add 2% is a ceiling, not a floor. A quarter in which 10% of holders want out would leave most of them holding shares until the next window, with no secondary market to sell into. ARK has filed to register an exchange-listed Class X (proposed ticker ARKV) and offers tokenized access through Securitize; neither changes the exit for existing Class D, S and U holders today.

That is the trade against DXYZ and VCX in one line. The listed funds let you place a sell order whenever the exchange is open and tell you nothing about the price; ARKVX tells you the price basis and nothing about when, beyond the quarterly calendar.

Which fund has more exposure to Anthropic, OpenAI or SpaceX?

Short answer

The three snapshots are dated differently and measured on different bases, so they can be laid side by side but not ranked as current exposure. Anthropic: VCX 16.5% of net assets (March 31, 2026), DXYZ 14.4% of its portfolio including cash (June 30, 2026), ARKVX 4.45% of the fund (October 31, 2026). OpenAI: VCX 12.4%, ARKVX 7.70%, DXYZ 2.6%. SpaceX: DXYZ 10.6%, ARKVX 5.79%, and not among the five largest issuers VCX named. DXYZ had deployed $169 million more by August 27, so its June weights are low for today; ARKVX's are the freshest.

The weights are not measured on the same day or the same base, which matters more here than usual. ARKVX publishes a monthly top ten on its site, most recently as of October 31, 2026, against net assets of $1,309 million. DXYZ's figures are economic exposure as a share of its investment portfolio at June 30, 2026, a date on which 57.5% of net assets sat in a money market fund waiting to be deployed; the fund says it deployed $169 million more by August 27, so the current weights are higher than the June table shows and will not be reported until the September 30 holdings filing. VCX's figures are from its March 31, 2026 annual report as a share of net assets, and the June 30 holdings report lists 62 positions without a look-through.

The rest of each list is where the funds differ. ARKVX's top ten includes Kalshi (5.89%), Ayar Labs (5.73%), Tenstorrent (4.22%), Stripe (4.10%), Lila Sciences (3.97%), Crusoe (3.52%) and Figure AI (2.48%), and 22.59% of the fund is in public companies after SpaceX listed in June 2026. DXYZ's exposure after its top three runs through OpenEvidence, Shield AI, Databricks and Revolut at 1% to 2% each, with the AI theme nearly half of deployed capital. VCX adds Databricks at 14.1%, Anduril at 5.5% and Ramp at 4.1%, plus 4.56% in data-center asset-backed securities.

Two structural points sit under the weights. DXYZ holds its largest positions through special purpose vehicles, some of which own forward contracts for shares to be delivered by unidentified existing shareholders rather than the shares themselves, and two of its twenty SPVs carry 20% and 10% carried interest. ARKVX and VCX also use third-party vehicles whose fees and carry do not appear in the funds' expense ratios. All three carry most of the book at Level 3, valued by the adviser.

The AltStreet Take

The fee debate is a distraction. The three funds' latest reported ratios are 2.57%, 2.82% and 2.90%, one audited for a full year, one annualized from an unaudited half year, one net of a waiver, and the three management fees are charged on three different bases: VCX on net assets, DXYZ on gross assets including cash, ARKVX on net assets with a cap ARK cannot recoup. Those differences are real and they are small next to what the listing structure does to the price.

The year to November 2026 has shown both sides of that. VCX went from a 75.7% premium on September 8 to a discount on November 6; DXYZ went from a 151% premium in May to roughly 29% below a stale NAV. DXYZ's filings document the issuance: $959.6 million of at-the-market proceeds in the first half of 2026, accreting NAV to existing holders and adding supply. VCX's September supplement authorizes up to $1 billion of sales; AltStreet located no filing confirming sales under it by November 8, 2026. Both say plainly in their filings that buyers at a premium can lose money while NAV rises. AltStreet is describing a sequence, not assigning a cause, and the lesson is the one the filings themselves teach: look up the NAV and its date before you look at the price.

ARKVX's case rests on not having a market price. That removes the premium risk and replaces it with a quarterly window and ARK's marks on a portfolio that was 68% Level 3 at July 31, 2026. The repurchase record so far is complete fulfillment, and the terms allow proration. A holder who wants NAV-based pricing and can plan around four windows a year is who the fund is built for; a holder who may need to sell in a week is not, and the fund's pending Class X listing would create a second price for a different share class, not a market for the one most retail buyers own. The name changes to ARK Venture & Innovation Fund on November 24, 2026; the structure does not.

How do fees and fund performance compare on the same basis?

Short answer

Expense ratios from the latest shareholder reports, on three different bases: VCX 2.57% for its audited year to March 31, 2026 (its September 2026 prospectus estimates 3.40% at the offering price), DXYZ 2.82% annualized from an unaudited half year (4.53% in audited 2025), ARKVX 2.90% net of a waiver (3.45% gross) for its audited year to July 31, 2026. NAV total returns for those periods: 68.39%, 72.12% and 62.94%. The caveat on DXYZ is that its own highlights attribute most of its NAV growth to selling shares above NAV rather than to the portfolio, and the caveat on both listed funds is that a shareholder earns the share-price return, which for DXYZ was (47.96)% in a year its NAV rose 209.59%.

Same basis means NAV total return over each fund's own reporting period, and the periods do not line up: ARKVX reports to July 31, VCX to March 31, DXYZ to December 31 with a June semi-annual. On those figures ARKVX returned 62.94% in fiscal 2026 and 30.26% a year since inception to July 31, 2026 (32.01% to September 30 per the fact sheet); VCX returned 68.39% in fiscal 2026 and 19.45% a year since July 2022; DXYZ returned 209.59% in 2025 and 72.12% in the first half of 2026, 81.80% a year since inception. All three were lifted by the 2025 to 2026 repricing of private AI companies and by the SpaceX listing.

DXYZ's NAV return needs its footnote attached. The fund's financial highlights split each year's NAV change between investment operations and the "impact of at-the-market offering": $3.54 from operations and $9.95 from issuance in 2025, $7.27 and $7.10 in the first half of 2026. Selling shares above NAV raises NAV per share for every existing holder, which is real value to them; it is not a portfolio return, and it stops when the premium does. The market-price return, which is what a shareholder actually earned, was (47.96)% in 2025 and (15.90)% in the first half of 2026.

On fees, read the base as well as the rate. DXYZ's 2.50% applies to average gross assets, so in a half year when 57.5% of the fund was a money market fund the adviser was paid 2.50% on cash; management fees were $11.15 million for the six months. ARKVX's 2.75% applies to net assets that are 68% ARK's own Level 3 marks. VCX's 1.85% is the lowest rate and the fund's shareholders kept it there by voting down a 2.50% proposal in February 2026. None of the three charges carried interest at the fund level; the vehicles underneath may.

Frequently asked questions

What is the difference between ARKVX, DXYZ and VCX?+

All three are closed-end funds registered under the Investment Company Act of 1940 that let any US investor own late-stage private technology companies. The difference is how you buy and sell. ARKVX, the ARK Venture Fund (renamed ARK Venture & Innovation Fund from November 24, 2026), is an interval fund: you buy shares from the fund at net asset value, $500 minimum, and sell only in its quarterly repurchase offers, which are sized at 5% of shares. DXYZ, Destiny Tech100, and VCX, the Fundrise Innovation Fund, are listed on the NYSE, so you buy and sell shares from other investors at whatever price the market sets, which can be far above or below NAV. Reported net assets, on different dates: DXYZ $1.63 billion at June 30, 2026, most of it then in a money market fund; ARKVX $1.31 billion at October 31, 2026; VCX $776.97 million at June 30, 2026.

Can I buy all three through a regular brokerage account?+

DXYZ and VCX, yes: they trade on the NYSE and any brokerage account can hold them, including IRAs. ARKVX is not exchange-listed. It is sold through participating brokerages and investment platforms, and which share class you receive (Class D ARKVX with a 0.15% servicing fee and no load, Class S ARKSX with 0.85% and a load of up to 3.50%, or Class U ARKUX with 0.75%) depends on the intermediary. ARK has filed to register a separate exchange-listed Class X (proposed ticker ARKV) and offers tokenized access through Securitize; as of November 8, 2026 neither gives existing ARKVX holders a market to sell into.

Is Fundrise's Innovation Fund the same fund as VCX?+

Yes. VCX is the NYSE ticker of the Fundrise Innovation Fund, LLC, which operated as a tender offer fund sold only through Fundrise from July 2022 until shareholders approved a listing on February 19, 2026. It began trading on March 19, 2026 at $31.25. Since the listing the fund has no tender program; the exchange is the only exit. The same shareholder meeting rejected a proposed increase in the management fee from 1.85% to 2.50%, so the fee stays at 1.85%.

Why do DXYZ and VCX trade above or below NAV?+

Because a listed closed-end fund's shares trade between investors, and the fund does not stand ready to buy them back at NAV. Supply, demand and sentiment set the price; the adviser sets the NAV, which for these funds is mostly Level 3 private valuations reported quarterly. DXYZ's own quarterly table pairs each quarter's high and low close with the NAV reported for that quarter: in the second quarter of 2024 the high close of $99.79 was 1,837.6% above the $5.15 quarterly NAV, and the lows of late 2025 and early 2026 were a few percent below NAV. VCX closed at $38.12 on September 8, 2026 against a $21.70 NAV, a 75.7% premium its prospectus supplement disclosed on its cover. Both have since fallen below their last reported NAVs: on November 6, 2026 DXYZ closed at $24.37 against its June 30 NAV of $34.30, and VCX at $20.05 against the September 8 NAV of $21.70. Those NAVs are two to four months old, so the discounts are comparisons with dated marks rather than same-day figures.

How do I sell ARKVX, and can my repurchase request be prorated?+

Through the fund's quarterly repurchase offer, submitted through your brokerage before the Repurchase Request Deadline (September 30, 2026 for the last offer; the offers run in March, June, September and December). The fund offers to buy back 5% of its outstanding shares at the NAV calculated on the Repurchase Pricing Date, which the notice says will normally be the same day as the request deadline, with the fund keeping discretion to price up to fourteen days later. If holders tender more than 5%, the fund may add up to 2% and otherwise buys pro rata, so yes, a request can be prorated. In the four offers of the fiscal year to July 31, 2026, holders tendered 1.50% to 4.23% of shares and every share tendered was repurchased. A repurchase is a taxable event and the NAV you receive is set after the deadline, not when you submit.

Which fund has more exposure to Anthropic, OpenAI or SpaceX?+

On each fund's latest disclosure, which are dated differently: ARKVX at October 31, 2026 held OpenAI at 7.70%, SpaceX at 5.79% and Anthropic at 4.45% of the fund, with Kalshi (5.89%) and Ayar Labs (5.73%) also in its top five. DXYZ at June 30, 2026 held Anthropic at 14.4%, SpaceX at 10.6% and OpenAI at 2.6% of its portfolio including cash, with 57.5% of net assets in a money market fund at that date and $169 million more deployed by August 27. VCX at March 31, 2026 held Anthropic at 16.5%, Databricks at 14.1% and OpenAI at 12.4% of net assets; SpaceX does not appear among the five largest economic issuers it named. On those snapshots VCX showed the heaviest Anthropic and OpenAI weights and DXYZ the heaviest SpaceX weight; ARKVX's OpenAI weight sat between the other two. The dates and denominators differ, so the figures are last published weights, not a ranking of exposure today.

How much portfolio exposure do I get per $100 at today's share price?+

Using the November 6, 2026 closes against each fund's last reported NAV: ARKVX is bought from the fund at NAV, so $100 buys $100 of NAV (the last NAV disclosed in a filing was $59.45 on August 31, 2026). DXYZ at $24.37 against a June 30 NAV of $34.30 buys about $141 of June-dated NAV per $100, a 29% discount. VCX at $20.05 against a September 8 NAV of $21.70 buys about $108 of NAV per $100, a 7.6% discount. The caveat is the dates: DXYZ's NAV is four months old and the fund says it deployed $169 million of cash into new positions after June 30, and VCX's is two months old. A discount to a stale NAV is not the same as a discount to current value.

How do fees and fund performance compare on the same basis?+

Expense ratios from each fund's latest shareholder report, which are not on one basis: ARKVX 2.90% net of a waiver (3.45% gross) for the audited year to July 31, 2026, on a 2.75% management fee; DXYZ 2.82% annualized from the unaudited six months to June 30, 2026 (4.53% for audited 2025), on a 2.50% fee charged on gross assets including cash; VCX 2.57% for the audited year to March 31, 2026, on a 1.85% fee, while its September 2026 prospectus supplement estimates 3.40% at the offering price. NAV total returns for the same periods: ARKVX 62.94%, DXYZ 72.12% for the half year (209.59% for 2025, of which the fund attributes $9.95 of the $13.49 NAV rise to selling shares above NAV), VCX 68.39%. Those are returns at NAV. A DXYZ or VCX shareholder earns the share-price return, which can diverge sharply: DXYZ's market-price return was (47.96)% in 2025 while its NAV return was 209.59%.

What tax forms do these funds send?+

Form 1099 from all three; none passes a Schedule K-1 from the underlying vehicles. ARKVX is taxed as a regulated investment company and paid no distribution in fiscal 2026. DXYZ intends to qualify as a regulated investment company and has paid no distributions in any reported period. VCX elected regulated investment company status for its year ended March 31, 2026 after three and a half years as a C corporation, so gains that accrued in those years remain subject to corporate tax if realized within five years; it had accrued $3.85 million of deferred tax inside NAV at March 31, 2026. All three fit in an IRA; VCX and DXYZ as listed stock, ARKVX if the custodian holds unlisted closed-end funds.

Related records on AltStreet

Disclosures:AltStreet has no commercial relationship with ARK Investment Management LLC, ARK Venture Fund, Destiny Tech100 Inc., DX Advisors LLC, Fundrise, Rise Companies Corp, Fundrise Advisors, LLC or Fundrise Innovation Fund, LLC, holds no shares of any fund named here, and received no compensation for this comparison. ARKVX figures are from the filings of ARK Venture Fund (CIK 1905088): the annual report on Form N-CSR for the year ended July 31, 2026 (accession 0001213900-26-107607), the repurchase offer notice of September 2, 2026 (accession 0001213900-26-096448, which states the August 31, 2026 NAV of $59.45), the prospectus supplement of November 6, 2026 announcing the name change (accession 0001213900-26-116907), and the fund's fact sheet and holdings as published on ark-funds.com as of October 31, 2026. DXYZ figures are from the filings of Destiny Tech100 Inc. (CIK 1843974): the semi-annual report on Form N-CSRS for the period ended June 30, 2026 (accession 0001213900-26-095201), the annual report for 2025 (accession 0001213900-26-025304), the shelf registration of May 26, 2026 and prospectus supplement of August 31, 2026 (accession 0001575872-26-000627), and the exposure table on destiny.xyz as of June 30, 2026. VCX figures are from the filings of Fundrise Innovation Fund, LLC (CIK 1867090): the annual report on Form N-CSR for the year ended March 31, 2026 (accession 0001435109-26-000093) and its amendment, the Form N-PORT for June 30, 2026 (accession 0001867090-26-000109), and the prospectus supplement of September 10, 2026 (accession 0001213900-26-098534). Share prices of $24.37 (DXYZ) and $20.05 (VCX) are market data for the November 6, 2026 close and are not filed figures; the discounts quoted measure them against each fund's last NAV disclosed in a filing (June 30, 2026 for DXYZ, September 8, 2026 for VCX), so they span different dates and are approximations, not same-day premium calculations. Dollar scenarios are arithmetic on the cited figures and exclude brokerage commissions and taxes. Return figures are historical and do not guarantee future results. This is not investment advice. AltStreet rating systems are proprietary and not universal standards. All investors should consult a qualified financial adviser before making investment decisions.

Last updated: November 8, 2026 · https://altstreet.investments/guides/arkvx-vs-dxyz-vs-vcx